← All trials
NCT05811377
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 29, 2023
- Primary completion
- Oct 12, 2024
- Completion date
- Oct 12, 2025
- First posted
- Apr 13, 2023
- Last posted
- Sep 21, 2023
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PittsburghLead sponsor
- National Institutes of Health (NIH)Collaborator
- University of PittsburghOverall official - principal investigator
- University of PittsburghSponsor investigator
- Lipella Pharmaceuticals, Inc.Collaborator
- University of PittsburghOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.